<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Screening tests in children and adolescents</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Screening tests in children and adolescents</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Screening tests in children and adolescents</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy R Kelly, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The schedule of and recommendations for common screening tests in children in the United States will be reviewed here. The specific diseases and conditions are discussed separately.</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW</span></p><p class="headingAnchor" id="H3"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Screening is defined as testing for disease in an individual or population that appears to be healthy [<a href="#rid1">1</a>]. The goal of screening is to identify children who are at increased risk of disease and warrant additional testing.</p><p>The following characteristics of a disease render it a good candidate for screening [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Substantial morbidity or mortality occurs if the disease is untreated</p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence warrants testing in an apparently healthy population</p><p class="bulletIndent1"><span class="glyph">●</span>The existence of a preclinical phase is detectable by the test</p><p class="bulletIndent1"><span class="glyph">●</span>A cost-effective treatment is available</p><p class="bulletIndent1"><span class="glyph">●</span>Preclinical detection of disease provides some benefit (eg, improved prognosis, ease of treatment, decreased risk of transmission to others)</p><p></p><p>Screening tests for diseases conducive to screening should [<a href="#rid1">1,2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Be easy to perform and interpret</p><p class="bulletIndent1"><span class="glyph">●</span>Measure something directly related to the disease</p><p class="bulletIndent1"><span class="glyph">●</span>Have low risk, morbidity, and cost</p><p class="bulletIndent1"><span class="glyph">●</span>Be highly sensitive and specific</p><p></p><p>Adverse effects of screening that must be weighed against the potential benefits include [<a href="#rid2">2,3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>False-positive test results must be followed up</p><p class="bulletIndent1"><span class="glyph">●</span>False-negative test results may delay diagnosis</p><p class="bulletIndent1"><span class="glyph">●</span>The cost of the screening program may compete with the cost of diagnosis, treatment, or primary prevention efforts</p><p></p><p>Adverse effects of screening are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7570.html" rel="external">"Evidence-based approach to prevention", section on 'Unintended consequences of screening'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Test characteristics</span><span class="headingEndMark"> — </span>In choosing an appropriate screening test, the sensitivity, specificity, and predictive value of the test must be considered [<a href="#rid2">2,3</a>]. These concepts are depicted in the classic 2 x 2 table  (<a class="graphic graphic_table graphicRef77832" href="/z/d/graphic/77832.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2759.html" rel="external">"Glossary of common biostatistical and epidemiological terms"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Sensitivity – Proportion of individuals who have the disease and have a positive test result.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Specificity – Proportion of individuals who do not have the disease and have a negative test result.</p><p></p><p>The best screening tests have a high sensitivity (few false negatives) so that individuals who have the disease are identified by the screening test. A test that has a high specificity (few false positives) is also desired so that individuals are not erroneously labeled as having disease when they are disease free. (See  <a class="medical medical_review" href="/z/d/html/7570.html" rel="external">"Evidence-based approach to prevention", section on 'Performance of screening tests'</a>.)</p><p>In addition to sensitivity and specificity, interpretation of test results also depends upon the test's predictive value:</p><p class="bulletIndent1"><span class="glyph">●</span>Positive-predictive value – The proportion of patients with a positive test that have the disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Negative-predictive value – The proportion of patients with a negative test that do not have disease.</p><p></p><p>The predictive values (and the proportion of positive and negative evaluations that can be expected) depend upon the prevalence of a disease within a population. Thus, for given values of sensitivity and specificity, a patient with a positive test is more likely to truly have the disease if the patient belongs to a population with a high prevalence of the disease  (<a class="graphic graphic_figure graphicRef68072" href="/z/d/graphic/68072.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2759.html" rel="external">"Glossary of common biostatistical and epidemiological terms"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Types of screening</span><span class="headingEndMark"> — </span>There are two types of screening programs:</p><p class="bulletIndent1"><span class="glyph">●</span>Universal (or population) screening refers to the screening of every individual within a population</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Selective (targeted or risk-based) screening refers to the screening of individuals for whom there is reason to believe that the screening may be positive</p><p></p><p>Selective screening increases the positive predictive value of a test by increasing the prevalence of the disease in the population that is screened  (<a class="graphic graphic_figure graphicRef68072" href="/z/d/graphic/68072.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H6"><span class="h2">Screening guidelines</span><span class="headingEndMark"> — </span>In pediatric practice, screening is routinely performed for a number of conditions, as discussed below. For most of these conditions, there is a lack of direct evidence from randomized controlled trials supporting the beneficial effects of screening and/or quantifying the potential benefits and harms. The lack of evidence does not necessarily mean that screening is not beneficial, only that it has not yet been adequately tested.</p><p>When deciding whether screening should be performed, the potential benefits and harms of screening must be considered. The balance between risks and benefits varies depending upon the condition, the clinical circumstances of the child and family, the availability of resources, and the values that patients (or patients' caregivers) place on the potential benefits and harms [<a href="#rid4">4</a>].</p><p>For many conditions, screening is regulated by local, state, or federal policies. In addition, recommendations regarding screening for various conditions are made by several professional groups and updated periodically. In the United States, these groups include:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fperiodicityschedule&amp;token=IQxLzDq4doJGUgaZgeIY0%2BqtuCtiZ%2FkyV%2B6NxNljOS%2B57AocU7z3BkPyVrbISXnl&amp;TOPIC_ID=2872" target="_blank">The American Academy of Pediatrics and Bright Futures</a> [<a href="#rid5">5-7</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aafp.org%2Ffamily-physician%2Fpatient-care%2Fclinical-recommendations.html&amp;token=tQMtX%2FVzAT2opBlxaE78Ydqf1NejRNmSdJI0Gb8sGcT7%2FGB%2BvT7XwTwnebofEoEAOVnDBifxLJAvZXPtIlop6BNxtMLZgvKVw4gbKMLGe0k%3D&amp;TOPIC_ID=2872" target="_blank">The American Academy of Family Physicians</a> [<a href="#rid8">8</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendations&amp;token=%2F3Jz2g2X5aTCSCHbzEyhg1ZiQA74QeEGxB1cvV41o4wJ3oahg3l9hlUTLYFkpWhhYxJgXtXcIWmxt0HrWcMgNvJwswKyUIsFA2QINt95b3c%3D&amp;TOPIC_ID=2872" target="_blank">The United States Preventive Services Task Force</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2F&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLD9buAaUkYyjEn%2FwkZF36ro%3D&amp;TOPIC_ID=2872" target="_blank">The Centers for Disease Control and Prevention</a></p><p></p><p>Recommendations regarding screening vary from country to country. The information below focuses on screening in the United States. A discussion of screening recommendations for other countries is beyond the scope of this topic review. Policies for individual countries may be available online (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.gov.uk%2Ftopic%2Fpopulation-screening-programmes&amp;token=oFXY00xAvJLKETc1%2BHG9HPXUmfyP6bq5UJIW9WCXitKECWHmpwjOk%2BRAE3Lmb%2Flw5VhxScrb3pdZmBx8ayMX3A%3D%3D&amp;TOPIC_ID=2872" target="_blank">United Kingdom</a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fcanadiantaskforce.ca%2F&amp;token=ihJ20MNAS8xt47xhpUChvqC7%2FbJocd5aHQuo%2FRgvY%2BbG9JgI0DtFWeXThpRMZLbu&amp;TOPIC_ID=2872" target="_blank">Canada</a>).</p><p class="headingAnchor" id="H1126823507"><span class="h2">State mandates for school screening</span><span class="headingEndMark"> — </span>Within the United States, each state has its own mandates for school health screening. Most states require schools to assess students' vision and hearing at specific ages. In addition, some states require screening for oral health problems, elevated body mass index, type 2 diabetes, asthma, or scoliosis. The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fstatepolicies.nasbe.org%2Fhealth%2Fstates&amp;token=Mswx8g1rHfbx9wfMv7kwntBBKrSt7NwGbgT0uI1J3ko0s9zbfcAzOuvV3GBHWJgzysPYxyAlwCd%2Bi%2BaE%2F2PoxA%3D%3D&amp;TOPIC_ID=2872" target="_blank">National Association of State Boards of Education</a> provides information regarding state-specific mandates for school health screening.</p><p class="headingAnchor" id="H7"><span class="h1">COMMON SCREENING TESTS IN PEDIATRICS</span></p><p class="headingAnchor" id="H8"><span class="h2">Newborn genetic and metabolic screen</span><span class="headingEndMark"> — </span>Screening newborns for genetic and metabolic disease is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4980.html" rel="external">"Overview of newborn screening"</a>.)</p><p class="headingAnchor" id="H1801732965"><span class="h2">Newborn bilirubin screening</span><span class="headingEndMark"> — </span>In the United States, a systematic approach to screening for hyperbilirubinemia is recommended for all term and late preterm infants. Newborn hyperbilirubinemia screening is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5008.html" rel="external">"Unconjugated hyperbilirubinemia in term and late preterm newborns: Screening"</a>.)</p><p class="headingAnchor" id="H67790485"><span class="h2">Critical congenital heart disease</span><span class="headingEndMark"> — </span>We agree with recommendations to screen all newborns for critical congenital heart disease using pulse oximetry. The screening procedure, criteria for a positive screen, and assessment of infants with a positive screen are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Hearing screen</span><span class="headingEndMark"> — </span>Hearing loss in newborns and young children may be associated with delays in speech, language, and cognitive development. Causes of hearing loss in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6308.html" rel="external">"Hearing loss in children: Etiology"</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Newborns</span><span class="headingEndMark"> — </span>Newborn hearing screening is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">"Screening the newborn for hearing loss"</a>.)</p><p class="headingAnchor" id="H11"><span class="h3">Infants and children</span><span class="headingEndMark"> — </span>We suggest a hearing risk assessment at all health maintenance visits and periodic hearing screening for all children between 4 and 21 years of age, in agreement with the American Academy of Pediatrics (AAP)/Bright Futures guidelines [<a href="#rid5">5,6</a>]. Hearing screening for infants, children, and adolescents is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">"Hearing loss in children: Screening and evaluation"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Vision screen</span><span class="headingEndMark"> — </span>Vision screening throughout childhood and adolescence helps to detect amblyopia, strabismus, and defects in visual acuity  (<a class="graphic graphic_table graphicRef62277" href="/z/d/graphic/62277.html" rel="external">table 2</a>). It is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6261.html" rel="external">"Vision screening and assessment in infants and children", section on 'Vision screening'</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Developmental screening</span><span class="headingEndMark"> — </span>The AAP/Bright Futures guidelines recommend developmental screening at 9, 18, and 30 months of age and screening for autism spectrum disorder at 18 and 24 months of age [<a href="#rid5">5,6</a>]. Developmental surveillance is recommended at all other preventive health visits. Developmental screening is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care", section on 'Approach to screening'</a> and  <a class="medical medical_review" href="/z/d/html/589.html" rel="external">"Autism spectrum disorder in children and adolescents: Surveillance and screening in primary care", section on 'Approach to ASD surveillance and screening'</a>.)</p><p class="headingAnchor" id="H3891821615"><span class="h2">Behavioral/social/emotional screening</span><span class="headingEndMark"> — </span>The AAP/Bright Futures guidelines recommend behavioral, social, and emotional screening at each health maintenance visit [<a href="#rid5">5,6</a>]. Behavioral, social, and emotional screening is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care", section on 'Approach to screening'</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Iron deficiency</span><span class="headingEndMark"> — </span>The AAP/Bright Futures guidelines recommend risk assessment for iron deficiency anemia at four months of age and measurement of hemoglobin or hematocrit at 12 months of age [<a href="#rid5">5</a>]. They also suggest repeat risk assessment at 15, 18, 24, 30, and 36 months of age and annually thereafter. The risk assessment at four months of age includes history of prematurity or low birth weight, and diet (ie, use of low-iron formula or not receiving iron-fortified formula) [<a href="#rid9">9,10</a>]. Risk assessment after one year of age includes questions about socioeconomic status, limited access to food, diets low in iron (eg, vegetarian diet), exposure to lead, and excessive menstrual bleeding (for females who are menstruating) [<a href="#rid9">9,10</a>]. The AAFP and USPSTF found insufficient evidence to recommend for or against routine screening for iron deficiency anemia in asymptomatic children aged 6 to 24 months [<a href="#rid8">8,11</a>].</p><p>Screening for iron deficiency in infants, children, and adolescents is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Screening recommendations'</a> and  <a class="medical medical_review" href="/z/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents", section on 'Screening'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Lead poisoning</span></p><p class="headingAnchor" id="H1176922494"><span class="h3">Background</span><span class="headingEndMark"> — </span>In October 2021, the Centers for Disease Control and Prevention (CDC) lowered the population-based blood lead reference value from 5 mcg/dL (0.24 micromol/L) to 3.5 mcg/dL (0.17 micromol/L) [<a href="#rid12">12</a>]. The 2021 reference value is based on the 97.5<sup>th</sup> percentile of the blood lead level (BLL) distribution among children age one to five years in the National Health and Nutrition Examination Surveys from 2015-2016 and 2017-2018.</p><p>The use of a reference value rather than a threshold for toxicity or level of concern was initiated in 2012 to underscore the absence of a specific threshold for lead's irreversible neurodevelopmental effects and to emphasize primary prevention [<a href="#rid13">13,14</a>]. The CDC Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) recommends that clinicians educate families about prevention of lead exposure and provide environmental assessments to identify sources of lead exposure <strong>before</strong> testing children for lead poisoning. Blood lead screening remains necessary to identify children for whom primary prevention is unsuccessful [<a href="#rid15">15</a>].</p><p>The goal of primary prevention is to minimize the neurodevelopmental effects of lead poisoning through source control and early detection. (See  <a class="medical medical_review" href="/z/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6493.html" rel="external">"Childhood lead poisoning: Exposure and prevention"</a>.)</p><p>As the prevalence of childhood lead poisoning declines, there has been a move from screening all children (universal screening) to targeted screening of children at increased risk [<a href="#rid16">16,17</a>]. The AAP/Bright Futures guidelines and the ACCLPP suggest that screening for lead poisoning should be done in accordance with federal, state, and local laws as applicable [<a href="#rid5">5,6,13,15</a>]. Information regarding state screening plans is available through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fnceh%2Flead%2Fprograms%2Fdefault.htm&amp;token=e5goV%2F%2B8wkYV5jpWnh1WFYZqXSGTPRpIjOF4dSz4wLWegiSbNV62JDR1qV3HkXJs5FoGotUDWHlUbZNEAw9%2FKA%3D%3D&amp;TOPIC_ID=2872" target="_blank">CDC</a>. For children who live in states that do not have a state screening program in place, we suggest universal lead testing during the ages of peak exposure; the AAP/Bright Futures guidelines and the ACCLPP suggest universal lead testing for such children at ages 12 and 24 months [<a href="#rid6">6,13,15</a>]. (See  <a class="medical medical_review" href="/z/d/html/6493.html" rel="external">"Childhood lead poisoning: Exposure and prevention"</a>.)</p><p>The USPSTF found insufficient evidence to assess the benefits and harms of screening for elevated BLLs in asymptomatic children ≤5 years of age [<a href="#rid17">17,18</a>]. They found no direct evidence from controlled studies that screening children resulted in improved health outcomes (eg, cognitive problems, behavior problems, learning disorders) [<a href="#rid17">17</a>]. For children with elevated BLL, they found conflicting or insufficient evidence regarding the effectiveness of early detection and intervention (eg, counseling, nutritional intervention, residential hazard control, chelation) in reducing BLLs.</p><p class="headingAnchor" id="H18"><span class="h3">Targeted testing</span><span class="headingEndMark"> — </span>We agree with the AAP Council on Environmental Health suggestion for targeted testing for lead poisoning with BLL for children 12 to 24 months of age who live in communities or census block groups in the United States with one or more of the following [<a href="#rid15">15,19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate data on the prevalence of elevated BLLs</p><p class="bulletIndent1"><span class="glyph">●</span>≥25 percent of housing built before 1960</p><p class="bulletIndent1"><span class="glyph">●</span>≥5 percent of children 12 to 24 months of age with BLLs ≥5 mcg/dL (0.24 micromol/L)</p><p></p><p>In addition, children and adolescents ≤16 years of age who enter the United States as an immigrant, refugee, or international adoptee should be tested for blood lead concentration at the time of arrival (or at the initial pediatric health care visit if the results of the arrival test are not available) [<a href="#rid16">16,20-22</a>].</p><p>Lead testing should be repeated three to six months after initial testing in [<a href="#rid20">20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Children ≤6 years of age, regardless of initial test results</p><p class="bulletIndent1"><span class="glyph">●</span>Children age 7 to 16 years of age if initial BLL was ≥3.5 mcg/dL (0.17 micromol/L)</p><p class="bulletIndent1"><span class="glyph">●</span>Children &gt;7 years of age who have a risk factor (eg, environmental exposure risk factor, sibling with BLL ≥3.5 mcg/dL [0.17 micromol/L]), regardless of initial test result</p><p></p><p class="headingAnchor" id="H19"><span class="h3">Lead risk assessment</span><span class="headingEndMark"> — </span>The AAP/Bright Futures recommendations for preventive health care suggest that the risk for lead poisoning be assessed at 6, 9, 12, 18, and 24 months of age, and annually thereafter through six years of age [<a href="#rid6">6</a>]. The BLL should be checked if any risk is detected.</p><p>The risk of lead poisoning is increased in children who [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Live in or visit a home or child care facility with an identified lead hazard</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Live in or visit a home or child care facility that was built before 1978, but particularly before 1960, and is in poor repair or was renovated in the past six months [<a href="#rid13">13,15</a>]</p><p></p><p>Other exposures that may increase the risk of lead poisoning include folk remedies, certain types of ceramics, pewter cookware, and certain parental occupations (eg, smelting, soldering, auto body repair) or hobbies  (<a class="graphic graphic_table graphicRef53953" href="/z/d/graphic/53953.html" rel="external">table 3</a>) [<a href="#rid16">16,17</a>]. Patient risk factors include inadequate nutrition, frequent hand-mouth activity, and developmental disabilities. Abused or neglected children also should be considered for blood lead testing [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/6493.html" rel="external">"Childhood lead poisoning: Exposure and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis", section on 'History'</a>.)</p><p>Screening for and management of lead poisoning in pregnant and lactating women is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2773.html" rel="external">"Lead exposure, toxicity, and poisoning in adults", section on 'Pregnancy and breastfeeding'</a>.)</p><p class="headingAnchor" id="H1801416223"><span class="h3">Measurement of BLL</span><span class="headingEndMark"> — </span>Measurement of the BLL is the test for lead poisoning. The blood lead reference value (ie, 3.5 mcg/dL [0.17 micromol/L] is used to guide <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fnceh%2Flead%2Fadvisory%2Facclpp%2Factions-blls.htm&amp;token=SAaWvcddKHurbqqHiKeMZyA5pQISBAYj9w882JO04Bpshvt8P5gY6OnbCGRZYXfT781ZzRnLReYdCXwBdpresXmwRJHp%2BVmyZNZT%2FU7mgYY%3D&amp;TOPIC_ID=2872" target="_blank">decisions about medical or environmental follow-up</a> for individual children, recognizing that the accuracy of BLLs between 3.5 and 5 mcg/dL (0.17 and 0.24 micromol/L ) is uncertain because they may be within the variability of the test [<a href="#rid12">12,23,24</a>]. (See  <a class="medical medical_review" href="/z/d/html/6494.html" rel="external">"Childhood lead poisoning: Management"</a>.)</p><p>The BLL may be measured on a capillary or venous blood sample. BLL measurement is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis", section on 'Lead levels'</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Oral health screening</span><span class="headingEndMark"> — </span>In accord with the AAP/Bright Futures guidelines, we suggest oral health risk assessment, including the need for <a class="drug drug_pediatric" data-topicid="13312" href="/z/d/drug information/13312.html" rel="external">fluoride</a> supplementation, at six and nine months of age and referral to a dental home at one year of age or as soon thereafter as possible, if a dental home is available [<a href="#rid5">5,6</a>]. Oral health risk assessment should continue at 12, 18, 24, and 30 months and yearly from three to six years of age until a dental home is established. (See  <a class="medical medical_review" href="/z/d/html/6279.html" rel="external">"Preventive dental care and counseling for infants and young children", section on 'Risk assessment'</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Tuberculosis</span><span class="headingEndMark"> — </span>We agree with the AAP/Bright Futures guidelines suggesting tuberculosis risk assessment by one month of age, at ages 6, 12, and 24 months, and annually thereafter [<a href="#rid5">5,6</a>]. Tuberculosis terminology is evolving and inconsistent  (<a class="graphic graphic_table graphicRef132526" href="/z/d/graphic/132526.html" rel="external">table 4</a>). Factors associated with increased risk of acquiring tuberculosis infection or progressing to tuberculosis disease are listed in the table  (<a class="graphic graphic_table graphicRef134991" href="/z/d/graphic/134991.html" rel="external">table 5</a>). Testing for tuberculosis infection in children is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8020.html" rel="external">"Tuberculosis infection (latent tuberculosis) in children", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H22"><span class="h2">Urinalysis</span><span class="headingEndMark"> — </span>The AAP no longer recommends a screening urinalysis for children [<a href="#rid5">5,6,25,26</a>].</p><p class="headingAnchor" id="H571169040"><span class="h2">Hypertension</span><span class="headingEndMark"> — </span>We agree with the AAP/Bright Futures recommendations for hypertension screening [<a href="#rid5">5,27</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>For children without risk factors or conditions associated with hypertension  (<a class="graphic graphic_table graphicRef114637 graphicRef114656" href="/z/d/graphic/114637.html" rel="external">table 6A-B</a>), we measure blood pressure (BP) annually at health supervision visits, beginning at age three years.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For children &lt;3 years with risk factors for hypertension  (<a class="graphic graphic_table graphicRef114637" href="/z/d/graphic/114637.html" rel="external">table 6A</a>), we measure BP at all health supervision visits.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For children ≥3 years with risk factors for hypertension  (<a class="graphic graphic_table graphicRef114656" href="/z/d/graphic/114656.html" rel="external">table 6B</a>), we measure BP at all health encounters.</p><p></p><p>For screening purposes in children &lt;13 years, the threshold for additional evaluation is the 90<sup>th</sup> percentile BP for age and sex for a child whose height is at the 5<sup>th</sup> percentile (ie, the lowest 90<sup>th</sup> percentile BP for age and sex), which minimizes false negatives [<a href="#rid27">27</a>]. For screening purposes in male and female adolescents ≥13 years of age, the threshold for additional evaluation is systolic BP ≥120 mmHg or diastolic BP ≥80 mmHg [<a href="#rid27">27</a>]. However, many clinicians have access to an electronic medical record (EMR) that automatically calculates the child's BP percentile for age, sex, and actual height.</p><p class="bulletIndent1"><span class="glyph">●</span>For clinicians who have access to an EMR that calculates the child's BP percentile according to age, sex, and height according to the 2017 AAP guidelines<strong> </strong>[<a href="#rid27">27</a>], children whose BP is &gt;90<sup>th</sup> percentile for age, sex, and height require further evaluation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For clinicians who do not have access to an EMR that calculates the child's BP percentile according to age, sex, and height according to the 2017 AAP guidelines [<a href="#rid27">27</a>], BP screening thresholds by age and sex are provided in the table  (<a class="graphic graphic_table graphicRef114638" href="/z/d/graphic/114638.html" rel="external">table 7</a>).<strong> </strong>These values have a negative predictive value of &gt;99 percent [<a href="#rid28">28</a>]. They should be used <strong>only</strong> for identification of children and adolescents who need further evaluation.</p><p></p><p>The<strong> </strong>diagnosis of hypertension is based upon the child's age, sex, and actual height percentile and requires additional evaluation. It is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6087.html" rel="external">"Definition and diagnosis of hypertension in children and adolescents", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H2270583971"><span class="h2">Conditions that predispose to sudden cardiac death</span><span class="headingEndMark"> — </span>Screening for conditions that predispose to sudden cardiac death is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/85989.html" rel="external">"Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in children", section on 'Primary prevention of SCD'</a>.)</p><p class="headingAnchor" id="H4280194557"><span class="h2">Physical activity assessment</span><span class="headingEndMark"> — </span>Assessment of physical activity and motor skill development is an important component of health supervision visits [<a href="#rid29">29-31</a>]. Physical activity and play improve physical (eg, cardiovascular, musculoskeletal) and mental health and well-being [<a href="#rid29">29,32,33</a>]. (See  <a class="medical medical_review" href="/z/d/html/6474.html" rel="external">"Physical activity and strength training in children and adolescents: An overview", section on 'Physical activity'</a>.)</p><p>Assessment of physical activity encompasses asking about duration, intensity, and type of activity in addition to assessment of age-appropriate fundamental movement skills (eg, throwing, catching, running, jumping, striking, kicking, skipping) [<a href="#rid29">29</a>].</p><p>Recommended physical activity levels vary with age [<a href="#rid29">29,34,35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>0 through 11 months – Floor-based play several times per day; total of 30 minutes of tummy time while awake</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>1 through 2 years – ≥3 hours per day (any intensity) including ≥30 minutes of activity that is planned and directed by an adult (eg, taking a walk in the neighborhood, playing in a playground)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>3 through 5 years – ≥3 hours per day of any activities that develop gross motor skills (eg, running, catching)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>≥6 years – ≥1 hours per day of moderate or vigorous aerobic activity, with ≥3 days per week of vigorous activity (eg, running, jumping rope, skating), muscle-strengthening activity (eg, climbing jungle gyms, push-ups, resistance training), and bone-strengthening activity (eg, jumping rope, running, skipping)</p><p></p><p>We provide information about the benefits of physical activity for all children, including those with special health care needs. (See  <a class="medical medical_review" href="/z/d/html/6474.html" rel="external">"Physical activity and strength training in children and adolescents: An overview", section on 'Physical activity'</a>.)</p><p>For children whose physical activity level is lower than recommended or whose fundamental movement skills are below what is typical for age (eg, poor kicking skills at age six years or jumping skills at age eight years [<a href="#rid36">36</a>]) and whose caregivers are interested, we also provide information and resources about promotion of physical activity. Structured at-home programs may improve motor skills [<a href="#rid37">37</a>].</p><p>Resources include:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fen%2Fpatient-care%2Finstitute-for-healthy-childhood-weight&amp;token=DS4iKZ0qQcg%2FZ58OBlm5C6321iIekJh5Nbn5IRLWu8CNL12oHsfNCMDR8yRKZUd7ecoHZu9mU3%2BpuBvD%2F1XzHOSz1GcN3OPF5Wcs6IcdHa0%3D&amp;TOPIC_ID=2872" target="_blank">AAP Institute for Healthy Childhood Weight</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sport for Life: <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fsportforlife.ca%2Fportfolio-view%2Fdeveloping-physical-literacy-a-guide-for-parents-of-children-ages-0-to-12%2F&amp;token=ISgsaMhXjAlznNKsbJGjL17J6mMsymvOfGSTSzIjwMsytym8KILiZqH6hsvnVo6IcbTt5g7Fiq8HKCkjw5PTEz%2B7TtnhPDljYxRLAxcsBYfnr677YOqqwZx32%2F%2B8EH%2FbrwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=2872" target="_blank">Developing Physical Literacy: A Guide for Parents of Children ages 0 to 12</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.exerciseismedicine.org%2Feim-in-action%2Fhealth-care%2Fresources%2Frx-for-health-series%2F&amp;token=eZd%2BndAThd4LQ%2BGTDmAZyf8NwhWJfrsZFPgOTZoIfRoLP67Oza%2FXyeFdYhgTfCaGYINWHCkmTb1H9R%2B%2BTeQE%2BGZIBb303w8EsdDk%2F6UspkQ%3D&amp;TOPIC_ID=2872" target="_blank">Exercise is Medicine Prescription for Health</a> (provides handouts to promote physical activity in <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fexerciseismedicine.org%2Fwp-content%2Fuploads%2F2021%2F04%2FEIM_Rx-for-Health_Being-Active-with-Your-Young-Child.pdf&amp;token=qNy6TOZrCYucwOYI5%2B8qRYTZkLyHzer5z42RYv0JxOSq0xvXg4aobxV%2BCSCyO7gdplktPjIKV480GoG2%2BqRnkAr3zgeYZ7M1WcDx04OiW3oYKmFVSUtK8rxIEPvBol3kvTq%2BcGlmtuAoxvlQJ9rRR68AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=2872" target="_blank">children</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fexerciseismedicine.org%2Fwp-content%2Fuploads%2F2021%2F04%2FEIM_Rx-for-Health_Teens.pdf&amp;token=%2Fps7TndWBIwnitCWdIdsF7dIx234AtnPMViVwvcbLqrr2X%2BiB4KVvm7Y0GHZYzmmK7CMT0Ms0vK0lyGlLxxB5RnSqecqnycxzwjYr1TSB8Z5%2F16IjQWkEvifV3pPYmo3&amp;TOPIC_ID=2872" target="_blank">adolescents</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h2">Screening for dyslipidemia</span><span class="headingEndMark"> — </span>Our approach to screening for dyslipidemia uses a combination of universal and selective screening based on age and cardiovascular risk factors  (<a class="graphic graphic_algorithm graphicRef105367 graphicRef121848" href="/z/d/graphic/105367.html" rel="external">algorithm 1A-B</a>). It is generally consistent with the recommendations of the United States National Heart, Lung, and Blood Institute, AAP, American Heart Association, and American College of Cardiology [<a href="#rid38">38,39</a>].</p><p>Screening for dyslipidemia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">"Dyslipidemia in children and adolescents: Definition, screening, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3040375534"><span class="h2">Sickle cell disease or trait</span><span class="headingEndMark"> — </span>Screening for sickle cell disease or trait is routinely performed in the United States and many other countries. Screening for sickle cell disease has been part of newborn screening in all 50 states since 2006 [<a href="#rid40">40</a>]. Screening children and adolescents for sickle cell disease and sickle cell trait are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7113.html" rel="external">"Diagnosis of sickle cell disorders", section on 'Newborn screening'</a> and  <a class="medical medical_review" href="/z/d/html/7145.html" rel="external">"Sickle cell trait", section on 'Screening'</a>.)</p><p class="headingAnchor" id="H24"><span class="h2">Screening for sexually transmitted infections</span><span class="headingEndMark"> — </span>Recommendations for screening sexually active adolescents for sexually transmitted infections vary with age, sex, and sexual behavior  (<a class="graphic graphic_table graphicRef103391" href="/z/d/graphic/103391.html" rel="external">table 8</a>). (See  <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">"Screening for sexually transmitted infections", section on 'Screening recommendations'</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Cervical dysplasia screening</span><span class="headingEndMark"> — </span>For immunocompetent, asymptomatic, female adolescents, screening for cervical cancer usually begins no earlier than age 21 years. (See  <a class="medical medical_review" href="/z/d/html/7575.html" rel="external">"Screening for cervical cancer in resource-rich settings", section on 'Screening in average-risk patients'</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Nicotine, alcohol, and substance use</span><span class="headingEndMark"> — </span>In accord with the AAP/Bright Futures guidelines, we suggest annual screening for tobacco, alcohol, and substance use, typically beginning at age 11 years [<a href="#rid5">5,41-44</a>]. Asking about tobacco, alcohol, and substance use provides an opportunity for positive reinforcement of nonuse and may be necessary for clinical care (eg, choice of medication) [<a href="#rid45">45</a>]. Prevention of smoking in children is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14583.html" rel="external">"Prevention of smoking and vaping initiation in children and adolescents"</a>.)</p><p>The AAP encourages clinicians to begin discussing the dangers of drinking alcohol with patients as young as nine years of age [<a href="#rid46">46</a>]. Early initiation of this discussion is suggested because children begin to view alcohol positively between 9 and 13 years of age given the frequent exposure to alcohol advertising, because alcohol use is so common [<a href="#rid47">47</a>], and because early initiation is associated with increased risk of alcohol use disorder (AUD) [<a href="#rid48">48-50</a>]. In a multisite survey of 1193 rural adolescents, approximately 2 percent of those aged 12 through 14 years and 10 percent of those aged 15 through 20 years met the Diagnostic and Statistics Manual of Mental Disorders, 5<sup>th</sup> edition (DSM-5) criteria for AUD, according to self-reported frequency and quantity of alcohol use and DSM-5 AUD symptoms [<a href="#rid47">47</a>].</p><p>Data from the 2019 Youth Risk Behavior Surveillance System indicate that among high school students in the United States [<a href="#rid51">51,52</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 15 percent reported having their first drink of alcohol (more than a few sips) before they were 13 years old</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 8 percent reported having tried cigarette smoking (even one or two puffs) before they were 13 years old</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 6 percent reported having tried marijuana before they were 13 years old</p><p></p><p>Early alcohol and substance use has been associated with increased risk of unintentional injuries, motor vehicle crashes, unhealthy use and dependence during adulthood, and alcohol-related health and social problems during adulthood [<a href="#rid44">44,53,54</a>]. Binge drinking increases the risk of adverse outcomes [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/z/d/html/101699.html" rel="external">"Substance use disorder in adolescents: Epidemiology, clinical features, assessment, and diagnosis", section on 'Clinical consequences'</a>.)</p><p>Despite the lack of evidence to support the counseling of adolescents in the primary care setting against alcohol and substance use [<a href="#rid55">55</a>], the AAP/Bright Futures guidelines suggest risk assessment for alcohol and drug use yearly, typically beginning at age 11 years [<a href="#rid5">5,42</a>], although screening for alcohol use may begin as early as 9 years [<a href="#rid46">46</a>]. The USPSTF found insufficient evidence to assess the balance of benefits and harms of primary screening for and behavior counseling to prevent unhealthy alcohol use in adolescents &lt;18 years of age [<a href="#rid56">56</a>]. The USPSTF also found insufficient evidence to assess the balance of benefits and harms of primary screening for unhealthy drug use in adolescents &lt;18 years of age [<a href="#rid57">57</a>] or behavior counseling to prevent illicit drug use in children, adolescents, and young adults [<a href="#rid58">58-60</a>].</p><p>The AAP/Bright Futures guidelines suggest asking the adolescent directly about experimentation with or use of tobacco, alcohol, or drugs [<a href="#rid5">5,42</a>]. It is important to ask specifically about smokeless tobacco, electronic cigarettes, inhalants, anabolic steroids, and nonmedical use of prescription stimulants [<a href="#rid61">61-63</a>]. If substance use is reported, additional information is gathered regarding duration, amount, and frequency.</p><p>The AAP/Bright Futures guidelines suggest using the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fcrafft.org%2F&amp;token=s4O3UVeS%2BlLEMaXZaNu%2B4Sy8YmGdjtf6nOUgyes5bWQ%3D&amp;TOPIC_ID=2872" target="_blank">CRAFFT screen</a> to identify problematic substance use. The CRAFFT screen is a brief screening tool that has been validated in the adolescent primary care setting [<a href="#rid64">64,65</a>]. The six CRAFFT screening questions are asked if the adolescent endorses drinking alcohol, smoking marijuana or hashish, or using any other substance to get high during the previous 12 months. The CRAFFT screening questions include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>C</strong>(ar) – Have you ever ridden in a car driven by someone (including yourself) who was "high" or had been using alcohol or drugs?</p><p class="bulletIndent1"><span class="glyph">●</span><strong>R</strong>(elax) – Do you ever use alcohol or drugs to relax, feel better about yourself, or fit in?</p><p class="bulletIndent1"><span class="glyph">●</span><strong>A</strong>(lone) – Do you ever use alcohol or drugs while you are by yourself, alone?</p><p class="bulletIndent1"><span class="glyph">●</span><strong>F</strong>(orget) – Do you ever forget things you did while using alcohol or drugs?</p><p class="bulletIndent1"><span class="glyph">●</span><strong>F</strong>(riends) – Do your family or friends ever tell you that you should cut down on your drinking or drug use?</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>(rouble) – Have you ever gotten into trouble while you were using alcohol or drugs?</p><p></p><p>One point is scored for each "yes" answer. In a large, hospital-based adolescent clinic, a score of ≥2 had a sensitivity and specificity of 76 and 94 percent, respectively, for identifying problem use (use associated with adverse consequences), abuse (continued use despite harm), or dependence (associated with tolerance, withdrawal) [<a href="#rid64">64</a>]. Exploration of "yes" responses on the CRAFFT screen and of problems related to substance use may provide information that can be used in intervention [<a href="#rid41">41</a>]. In a multicenter observational study in 1573 Hispanic, Black, and White adolescents (12 through 18 years of age), the sensitivity and specificity of the CRAFFT screen were 98 percent (95% CI 91-100 percent) and 73 percent (95% CI 71-76 percent), respectively, for AUD and 88 percent (95% CI 83-92 percent) and 80 percent (95% CI 78-82 percent), respectively, for cannabis use disorder (using the Diagnostic Interview Schedule for Children Version IV as the reference standard) [<a href="#rid66">66</a>].</p><p>Other screening tools that can be administered by an interviewer or self-administered and are sensitive and specific in identifying substance use disorders (SUDs) as defined by the DSM-5 criteria include [<a href="#rid41">41</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The Brief Screener for Tobacco, Alcohol, and other Drugs (BSTAD) assesses the frequency of use during the past 30 days, 90 days, and year [<a href="#rid67">67</a>]. Cutoffs of ≥6 days for tobacco and ≥2 days for alcohol or marijuana correlated with problematic use. The BSTAD is available in the full text of reference [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Screening to Brief Intervention (S2BI) tool (available through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.mcpap.com%2FProvider%2FScreeningNToolkits.aspx&amp;token=5yLNPmHjkOhvnhOBCCm6DEwfFpSPxV%2B0Kbm9kCxR8TLxDmDxupD1VUFMxJXoZrz5jGAInvzdR6APtPaFpO3GAQ%3D%3D&amp;TOPIC_ID=2872" target="_blank">Massachusetts Child Psychiatry Access Program</a>) assesses the frequency of tobacco, alcohol, marijuana, and other/illicit drug use in the past year [<a href="#rid68">68</a>]. It discriminates among clinically relevant use categories: no SUD ("once or twice"), mild or moderate SUD ("monthly"), and severe SUD ("weekly or more") [<a href="#rid41">41</a>].</p><p></p><p>Alcohol-only screening tools may be used if time does not permit full substance screening [<a href="#rid46">46</a>]. One such <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.niaaa.nih.gov%2Falcohols-effects-health%2Fprofessional-education-materials%2Falcohol-screening-and-brief-intervention-youth-practitioners-guide&amp;token=0zJR%2BN6KmD1mHAJ969PlztJkjcMNuSDWoCnrSK8MHXiuCbA7yyXU%2BlxC%2FsXcg6evfMpIVX%2FFnRwMrr7C%2BcGIaFpYRVBjZWjih1pOXkTTsZ%2BFyapFB6RTB6fg%2FMkMkgX6400mmWPXTwXV6ve3vtiQ%2ByrfGUuJag2v56bUW%2B7q70k%3D&amp;TOPIC_ID=2872" target="_blank">screen</a> was developed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in collaboration with the AAP  (<a class="graphic graphic_table graphicRef104125" href="/z/d/graphic/104125.html" rel="external">table 9</a>) [<a href="#rid69">69</a>]. This screen focuses on friends drinking (an early warning signal and predictor of the patient's future drinking levels [<a href="#rid70">70</a>]) and frequency of drinking (a predictor of alcohol-related harm [<a href="#rid71">71</a>]). In a multicenter observational study in 1573 Hispanic, Black, and White adolescents (12 through 18 years of age), the sensitivity and specificity of the NIAAA/AAP screen were 87 percent (95% CI 76-94 percent) and 84 percent (95% CI 82-86 percent), respectively, for AUD (using the Diagnostic Interview Schedule for Children Version IV as the reference standard) [<a href="#rid66">66</a>]. A systematic review confirmed the accuracy of the NIAAA/AAP and other brief screening tools to detect AUD in adolescents, but the data were insufficient to determine whether such tools can detect unhealthy alcohol use [<a href="#rid72">72</a>].</p><p>The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fpublications.aap.org%2Fpediatrics%2Farticle%2F138%2F1%2Fe20161211%2F52568%2FSubstance-Use-Screening-Brief-Intervention-and%3Fautologincheck%3Dredirected%3FnfToken%3D00000000-0000-0000-0000-000000000000&amp;token=VZTgSidyG2dYhbsN8e4Lup71oU29Kqjwx9a3%2FLVK9TxwriG1d4HCVpVsKq64Ymwo9M6df3rGiwGcjpAdbSWQDApf9OVtNmCN8H4YEg759aIiidMLdxuUJM8%2Bjlw3agTXIRu5aQkB0sv3vARiWta%2FOXjuMwVP%2BG6ulHHxSoSF1q%2BZ82WalPdGx0sBeAcFND%2By&amp;TOPIC_ID=2872" target="_blank">AAP clinical report</a> provides additional information about screening, brief intervention, and referral to treatment [<a href="#rid41">41</a>]. The National Institute on Drug Abuse <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnida.nih.gov%2Fnidamed-medical-health-professionals&amp;token=IUkaTflBfEA1%2F4Xwxp541rA04LaAE3Riz8xurb5AsZhDRgaskRuz33RJNwNL2QkX6U0Y86R2SROb7WzE%2Ft3amQ%3D%3D&amp;TOPIC_ID=2872" target="_blank">website</a> provides resources related to addiction and offers access to screening tools for adolescent patients.</p><p>Smoking cessation and the diagnosis and management of alcohol use disorder and substance use disorder in adolescents are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6359.html" rel="external">"Management of smoking and vaping cessation in adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/101699.html" rel="external">"Substance use disorder in adolescents: Epidemiology, clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/120005.html" rel="external">"Substance use disorder in adolescents: Treatment overview"</a>.)</p><p class="headingAnchor" id="H67789792"><span class="h2">Depression and suicide risk screening</span><span class="headingEndMark"> — </span>In accord with the Bright Futures/AAP, we suggest universal screening for depression and suicide risk annually from age 12 through 21 years [<a href="#rid5">5,73</a>]. We also suggest targeted screening for depression in children ≥10 years and adolescents at high risk of depression, including those:</p><p class="bulletIndent1"><span class="glyph">●</span>With a personal or family history of depression, bipolar disorder, suicidality, substance use, or other psychiatric illness</p><p class="bulletIndent1"><span class="glyph">●</span>With significant psychosocial stressors (eg, family crises, physical or sexual abuse, neglect, other trauma)</p><p class="bulletIndent1"><span class="glyph">●</span>With frequent somatic complaints</p><p class="bulletIndent1"><span class="glyph">●</span>Who are in foster care or have been adopted</p><p></p><p>Depression is an important risk factor for suicide, which is among the leading causes of death for children and adolescents.</p><p>In nationwide surveys of high school students (2009 to 2019), the percentage of students who reported feeling so sad or hopeless every day for ≥2 weeks in a row that they stopped doing some usual activities increased from 26 to 37 percent [<a href="#rid74">74</a>]. Effective treatments for adolescent depression include medications (eg, selective serotonin reuptake inhibitors) and psychotherapy (cognitive behavioral therapy or interpersonal therapy). (See  <a class="medical medical_review" href="/z/d/html/1229.html" rel="external">"Suicidal behavior in children and adolescents: Epidemiology and risk factors", section on 'Epidemiology'</a> and  <a class="medical medical_review" href="/z/d/html/1231.html" rel="external">"Overview of prevention and treatment for pediatric depression", section on 'Acute treatment'</a>.)</p><p>There is limited evidence to guide the choice of a depression screening tool [<a href="#rid73">73</a>]. A number of tools have been evaluated in primary care practice, including depression-specific tools, broader psychosocial tools, and combined tools for depression and other psychiatric disorders. Providers are encouraged to choose a tool that will work best for their practice, patients, and health organizations. They are also encouraged to screen for suicidality [<a href="#rid75">75</a>]. (See  <a class="medical medical_review" href="/z/d/html/1230.html" rel="external">"Suicidal ideation and behavior in children and adolescents: Evaluation and management"</a>.)</p><p>The Patient Health Questionnaire-2 item screen (PHQ-2) has been validated in adolescents [<a href="#rid76">76</a>]. It consists of two questions [<a href="#rid77">77</a>]:</p><p>"Over the past two weeks, how often have you been bothered by any of the following problems:</p><p class="bulletIndent1"><span class="glyph">●</span>"Little interest or pleasure in doing things?"</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>"Feeling down, depressed, or hopeless?"</p><p></p><p>The responses for each question include "not at all" (0 points); "several days" (1 point); "more than half the days" (2 points); and "nearly every day" (3 points). Adolescents with a score of ≥3 should undergo additional assessment for depressive disorder. In a primary care sample of 499 adolescents, a PHQ-2 score ≥3 had a sensitivity of 74 percent and specificity of 75 percent for detecting major depression according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition [<a href="#rid76">76</a>]. Some practices choose to use a cut-off of 2 to increase sensitivity, but this must be weighed against the potential extra workload and decrease in clinic efficiency related to the increased number of false positives identified with the lower cut-off [<a href="#rid77">77</a>]. (See  <a class="medical medical_review" href="/z/d/html/1224.html" rel="external">"Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis", section on 'Assessment'</a>.)</p><p>Other validated depression screening tools for adolescents include the PHQ-9 Modified for Teens (in English or Spanish), the Kutcher Adolescent Depression Scale-6-item, and the Columbia Depression Scale (parent or teen version) [<a href="#rid78">78-81</a>]. These tools and scoring instructions are available in the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.gladpc.org%2F&amp;token=cR7TBaPRpkcc9qSGaKgOPg78pso5VJCc%2BZVr8OWNMIY%3D&amp;TOPIC_ID=2872" target="_blank">Guidelines for Adolescent Depression in Primary Care Tool Kit</a> [<a href="#rid82">82</a>]. In systematic reviews, the sensitivities of these tools ranged from 70 to 90 percent and specificities from 40 to 90 percent [<a href="#rid73">73,83</a>].</p><p>Studies in adult patients suggest that screening improves identification of depression (see  <a class="medical medical_review" href="/z/d/html/83887.html" rel="external">"Screening for depression in adults", section on 'Improved detection'</a>). Studies comparing outcomes among adolescents screened and not screened for depression are lacking [<a href="#rid73">73,84</a>]. However, in a randomized trial, adolescent patients with depressive symptoms who were identified in primary care and received six months of effective treatment (eg, psychotherapy and/or medication) had fewer depressive symptoms and improved mental health-related quality of life than those who received usual care [<a href="#rid85">85</a>].</p><p>The USPSTF recommends screening adolescents age 12 to 18 years for major depressive disorder [<a href="#rid86">86,87</a>]. They concluded that the evidence was insufficient to screen for major depressive disorder in younger children or to screen children and adolescents for suicidality.</p><p class="headingAnchor" id="H2049565827"><span class="h2">Anxiety screening</span><span class="headingEndMark"> — </span>Anxiety is characterized by excessive fear or worry that is associated with physical and emotional symptoms. Screening children and adolescents for anxiety is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/93408.html" rel="external">"Anxiety disorders in children and adolescents: Assessment and diagnosis", section on 'Screening and assessment'</a>.)</p><p class="headingAnchor" id="H1969775758"><span class="h2">Screening for poverty</span><span class="headingEndMark"> — </span>We agree with the AAP recommendation to screen for poverty during health care visits [<a href="#rid88">88</a>]. Screening for basic social needs (eg, food, housing, utilities, transportation) may uncover both obvious and less apparent economic difficulties associated with adverse health outcomes, less preventive care, and increased use of emergency care services [<a href="#rid89">89-98</a>]. Providers can then link the families with available community services (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.211.org%2F&amp;token=lSWsQWoL7xGXrVpCCV3qLMxooTEuIEJDA9YECUzrZvI%3D&amp;TOPIC_ID=2872" target="_blank">2-1-1</a>, a free and confidential helpline and website for people in North America) and/or provide high-quality written resources [<a href="#rid99">99</a>]. Although the accuracy of screening for poverty and other social determinants of health has not been proven [<a href="#rid100">100</a>], as one of multiple components of a comprehensive approach to patient and family engagement, screening may initiate a conversation about family concerns and priorities [<a href="#rid101">101</a>].</p><p>A variety of screening instruments may be used, including the single question: "Do you (ever) have difficulty making ends meet at the end of the month?" In a pilot study in a primary care practice, this question was 98 percent sensitive and 40 percent specific in identifying families with a need for community resources [<a href="#rid102">102,103</a>].</p><p>The <strong>W</strong>ell-child Care Visit, <strong>E</strong>valuation, <strong>C</strong>ommunity Resources, <strong>A</strong>dvocacy, <strong>R</strong>eferral, <strong>E</strong>ducation (WE CARE) survey instrument may prompt discussion of poverty-related topics and referral for community resources [<a href="#rid104">104</a>]; the survey instrument is available in the appendix of reference [<a href="#rid104">104</a>].</p><p>Other screens that may be used for specific needs include:</p><p class="bulletIndent1"><span class="glyph">●</span>Food – Endorsement of either of the following statements as often or sometimes true rather than never true is an accurate indication of food insecurity [<a href="#rid105">105-108</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>"Within the past 12 months we worried whether our food would run out before we got money to buy more."</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>"Within the past 12 months the food we bought just didn't last, and we didn't have money to get more."</p><p></p><p class="bulletIndent1">In a validation study, endorsement of either of these statements was 97 percent sensitive and 83 percent specific in identifying food insecurity compared with the 18-item <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ers.usda.gov%2Ftopics%2Ffood-nutrition-assistance%2Ffood-security-in-the-u-s%2Fsurvey-tools%2F&amp;token=wk%2FuVqqheE5p7emCkUzzwGEJY5OdcVVy2ngivvu7U7hY9nwaB2MVrw6rIFTk5xh47JoYa964O5Jd4f4URMWKHoeED1AoYfgIl6jPGwMFLGmJ4rBJQ3qI%2BeayIloRKOcb&amp;TOPIC_ID=2872" target="_blank">United States Department of Agriculture Household Food Security Survey</a>, a research tool from which the questions were taken [<a href="#rid106">106</a>].</p><p></p><p class="bulletIndent1">In a systematic review, household food insecurity was associated with behavioral, emotional, and developmental problems in children of all ages [<a href="#rid109">109</a>]. Children from families with food insecurity may warrant enhanced developmental/behavioral surveillance. (See  <a class="medical medical_review" href="/z/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care"</a>.)</p><p></p><p class="bulletIndent1">The AAP and Food Research &amp; Action Center have developed a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Ffrac.org%2Faaptoolkit&amp;token=ZNhjFrGHvg%2FPI34v3TK1CNtK1zUby4zQvZMVwRwdM4dqrx8duD1yun2l9Yo96%2BVf&amp;TOPIC_ID=2872" target="_blank">toolkit</a> to help clinician address food insecurity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Housing – Asking whether families have moved frequently in the past year or lived with another family for financial reasons helps to identify housing insecurity [<a href="#rid110">110</a>].</p><p></p><p>Screening for poverty may have unintended harms (eg, patient/family frustration if they have unrealistic expectations about the type or quality of resources and services that are available; patient/family feeling stigmatized if screening is limited to particular subgroups, etc) [<a href="#rid111">111</a>]. The risk of unintended harm can be minimized through care coordination, collaboration with service providers, involving the family in shared decision-making before making referrals, screening the entire practice population rather than subgroups (and explaining this screening strategy to families), and acknowledging and building on patient and family strengths.</p><p class="headingAnchor" id="H3072757752"><span class="h2">Intimate partner violence</span><span class="headingEndMark"> — </span>The process of asking about intimate partner violence is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/591.html" rel="external">"Intimate partner violence: Childhood exposure", section on 'The process of asking about caregiver intimate partner violence'</a> and  <a class="medical medical_review" href="/z/d/html/121477.html" rel="external">"Adolescent relationship abuse including physical and sexual teen dating violence"</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and goal of screening</strong> – Screening is defined as testing for disease in an individual or population that appears to be healthy. The goal of screening is to identify children who are at increased risk of disease and warrant additional testing. (See <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lead poisoning</strong> – Screening for lead poisoning should be performed in accordance with state laws as applicable. (See <a class="local">'Lead poisoning'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oral health</strong> – We suggest oral health risk assessment beginning at six months of age and referral to a dental home at one year of age or as soon thereafter as possible (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Oral health screening'</a> above and  <a class="medical medical_review" href="/z/d/html/6279.html" rel="external">"Preventive dental care and counseling for infants and young children", section on 'Risk assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tuberculosis </strong>– We agree with guidelines suggesting tuberculosis risk assessment  (<a class="graphic graphic_table graphicRef134991" href="/z/d/graphic/134991.html" rel="external">table 5</a>) by 1 month of age, at ages 6, 12, and 24 months, and annually thereafter. (See <a class="local">'Tuberculosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong> – We screen children without risk factors or conditions associated with hypertension by measuring blood pressure annually at health supervision visits, beginning at age three years. For children &lt;3 years with risk factors for hypertension  (<a class="graphic graphic_table graphicRef114637" href="/z/d/graphic/114637.html" rel="external">table 6A</a>), we measure BP at all health supervision visits. For children ≥3 years with risk factors for hypertension  (<a class="graphic graphic_table graphicRef114656" href="/z/d/graphic/114656.html" rel="external">table 6B</a>), we measure BP at all health encounters. (See <a class="local">'Hypertension'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alcohol, tobacco, and substance use</strong> – We suggest screening for alcohol, tobacco, and substance use annually, beginning at age 11 years (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Nicotine, alcohol, and substance use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Depression</strong> – We suggest screening adolescents for depression annually, beginning at age 12 years (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). (See <a class="local">'Depression and suicide risk screening'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poverty</strong> – Screening for poverty during health care visits may identify economic difficulties for which community services are available. (See <a class="local">'Screening for poverty'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other conditions</strong> – Screening for other conditions is discussed separately. These include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic and metabolic disease (see  <a class="medical medical_review" href="/z/d/html/4980.html" rel="external">"Overview of newborn screening"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hyperbilirubinemia (see  <a class="medical medical_review" href="/z/d/html/5008.html" rel="external">"Unconjugated hyperbilirubinemia in term and late preterm newborns: Screening"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Critical congenital heart disease (see  <a class="medical medical_review" href="/z/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hearing loss (see  <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">"Screening the newborn for hearing loss"</a> and  <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">"Hearing loss in children: Screening and evaluation"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vision screening (see  <a class="medical medical_review" href="/z/d/html/6261.html" rel="external">"Vision screening and assessment in infants and children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Developmental and behavioral/social/emotional problems, including anxiety:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care"</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/589.html" rel="external">"Autism spectrum disorder in children and adolescents: Surveillance and screening in primary care"</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/93408.html" rel="external">"Anxiety disorders in children and adolescents: Assessment and diagnosis", section on 'Screening and assessment'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Iron deficiency in infants and adolescents (see  <a class="medical medical_review" href="/z/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Screening recommendations'</a> and  <a class="medical medical_review" href="/z/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents", section on 'Screening'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dyslipidemia (see  <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">"Dyslipidemia in children and adolescents: Definition, screening, and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sexually transmitted infections (see  <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">"Screening for sexually transmitted infections", section on 'Screening recommendations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cervical cancer (see  <a class="medical medical_review" href="/z/d/html/7575.html" rel="external">"Screening for cervical cancer in resource-rich settings"</a>)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Minkovitz C, Wissow L. Evaluating and using laboratory tests. In: Oski's Pediatrics. Principles and Practice, 4th, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.95.</li><li class="breakAll">Fletcher RW, Fletcher SW. Prevention. In: Clinical Epidemiology The Essentials, 4th, Lippincott Williams &amp; Wilkins, Philadelphia 2005. p.147.</li><li><a class="nounderline abstract_t">Ades AE. Evaluating screening tests and screening programmes. Arch Dis Child 1990; 65:792.</a></li><li><a class="nounderline abstract_t">Barratt A, Irwig L, Glasziou P, et al. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 1999; 281:2029.</a></li><li class="breakAll">Bright Futures/American Academy of Pediatrics. Recommendations for Preventive Pediatric Health Care - Preventive Care/Periodicity Schedule. 2023. Available at: https://www.aap.org/en/practice-management/care-delivery-approaches/periodicity-schedule/ (Accessed on September 01, 2023).</li><li class="breakAll">Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2017.</li><li><a class="nounderline abstract_t">2022 Recommendations for Preventive Pediatric Health Care. Pediatrics 2022; 150.</a></li><li class="breakAll">American Academy of Family Physicians. Clinical Recommendations by Topic. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/recommendations-by-topic.html (Accessed on January 30, 2023).</li><li><a class="nounderline abstract_t">Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126:1040.</a></li><li class="breakAll">Anemia. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2017. p.279.</li><li><a class="nounderline abstract_t">Siu AL, US Preventive Services Task Force. Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement. Pediatrics 2015; 136:746.</a></li><li><a class="nounderline abstract_t">Ruckart PZ, Jones RL, Courtney JG, et al. Update of the Blood Lead Reference Value - United States, 2021. MMWR Morb Mortal Wkly Rep 2021; 70:1509.</a></li><li class="breakAll">Low level lead exposure harms children: A renewed call for primary prevention. Report of the Advisory Committee on Childhood Lead Poisoning Prevention. www.cdc.gov/nceh/lead/ACCLPP/Final_Document_030712.pdf (Accessed on January 27, 2023).</li><li class="breakAll">Centers for Disease Control and Prevention. https://www.cdc.gov/nceh/lead/prevention/default.htm (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">COUNCIL ON ENVIRONMENTAL HEALTH. Prevention of Childhood Lead Toxicity. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Wengrovitz AM, Brown MJ, Advisory Committee on Childhood Lead Poisoning, Division of Environmental and Emergency Health Services, National Center for Environmental Health, Centers for Disease Control and Prevention. Recommendations for blood lead screening of Medicaid-eligible children aged 1-5 years: an updated approach to targeting a group at high risk. MMWR Recomm Rep 2009; 58:1.</a></li><li><a class="nounderline abstract_t">Cantor AG, Hendrickson R, Blazina I, et al. Screening for Elevated Blood Lead Levels in Childhood and Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2019; 321:1510.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement. JAMA 2019; 321:1502.</a></li><li><a class="nounderline abstract_t">COUNCIL ON ENVIRONMENTAL HEALTH. Prevention of Childhood Lead Toxicity. Pediatrics. 2016;38(1):e20161493. Pediatrics 2017; 140.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Screening for lead during the domestic medical examination for newly arrived refugees. Available at: https://www.cdc.gov/immigrantrefugeehealth/guidelines/lead-guidelines.html (Accessed on January 30, 2023).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Elevated blood lead levels among internationally adopted children--United States, 1998. MMWR Morb Mortal Wkly Rep 2000; 49:97.</a></li><li><a class="nounderline abstract_t">Pezzi C, Lee D, Kennedy L, et al. Blood Lead Levels Among Resettled Refugee Children in Select US States, 2010-2014. Pediatrics 2019; 143.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Childhood lead poisoning prevention. Recommended actions based on blood lead level. https://www.cdc.gov/nceh/lead/advisory/acclpp/actions-blls.htm (Accessed on January 27, 2023).</li><li class="breakAll">Sample JA, Zajac L. Revised blood lead reference value: progress, but more work to be done. AAP News. October 28, 2021. https://www.aappublications.org/news/2021/10/28/bloodleadlevels102821 (Accessed on January 30, 2023).</li><li><a class="nounderline abstract_t">Sekhar DL, Wang L, Hollenbeak CS, et al. A cost-effectiveness analysis of screening urine dipsticks in well-child care. Pediatrics 2010; 125:660.</a></li><li class="breakAll">Choosing Wisely. American Academy of Pediatrics -- Section on Nephrology and the American Society of Pediatric Nephrology. July 2018. Available at: www.choosingwisely.org/societies/american-academy-of-pediatrics-section-on-nephrology-and-the-american-society-of-pediatric-nephrology/ (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140.</a></li><li><a class="nounderline abstract_t">Kaelber DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics 2009; 123:e972.</a></li><li><a class="nounderline abstract_t">Lobelo F, Muth ND, Hanson S, et al. Physical Activity Assessment and Counseling in Pediatric Clinical Settings. Pediatrics 2020; 145.</a></li><li class="breakAll">Promoting physical activity. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2017. p.193.</li><li><a class="nounderline abstract_t">Noritz GH, Murphy NA, Neuromotor Screening Expert Panel. Motor delays: early identification and evaluation. Pediatrics 2013; 131:e2016.</a></li><li><a class="nounderline abstract_t">Yogman M, Garner A, Hutchinson J, et al. The Power of Play: A Pediatric Role in Enhancing Development in Young Children. Pediatrics 2018; 142.</a></li><li><a class="nounderline abstract_t">García-Hermoso A, Alonso-Martínez AM, Ramírez-Vélez R, et al. Association of Physical Education With Improvement of Health-Related Physical Fitness Outcomes and Fundamental Motor Skills Among Youths: A Systematic Review and Meta-analysis. JAMA Pediatr 2020; 174:e200223.</a></li><li><a class="nounderline abstract_t">Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA 2018; 320:2020.</a></li><li><a class="nounderline abstract_t">Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020; 54:1451.</a></li><li class="breakAll">The Aspen Institute. Physical literacy in the United States. A model, strategic plan, and call to action. Available at: https://www.aspeninstitute.org/publications/physical-literacy-model-strategic-plan-call-action/ (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Staiano AE, Newton RL, Beyl RA, et al. mHealth Intervention for Motor Skills: A Randomized Controlled Trial. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5:S213.</a></li><li><a class="nounderline abstract_t">de Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation 2019; 139:e603.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Sickle Cell Disease Research. State-based monitoring for selected hemoglobinopathies. https://www.cdc.gov/ncbddd/hemoglobinopathies/features/keyfinding-state-based.html (Accessed on January 30, 2023).</li><li><a class="nounderline abstract_t">Levy SJ, Williams JF, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Substance Use Screening, Brief Intervention, and Referral to Treatment. Pediatrics 2016; 138.</a></li><li class="breakAll">Early adolescence: 11 through 14 year visits. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2017. p.733.</li><li class="breakAll">Promoting mental health. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2017. p.115.</li><li><a class="nounderline abstract_t">Ryan SA, Kokotailo P, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Alcohol Use by Youth. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">McCarty CA, Levy S, Harris SK. Alcohol Use Screening and Behavioral Counseling With Adolescents in Primary Care: A Call to Action. JAMA Pediatr 2019; 173:12.</a></li><li><a class="nounderline abstract_t">Siqueira L, Smith VC, COMMITTEE ON SUBSTANCE ABUSE. Binge Drinking. Pediatrics 2015; 136:e718.</a></li><li><a class="nounderline abstract_t">Clark DB, Martin CS, Chung T, et al. Screening for Underage Drinking and Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Alcohol Use Disorder in Rural Primary Care Practice. J Pediatr 2016; 173:214.</a></li><li><a class="nounderline abstract_t">Elsayed NM, Kim MJ, Fields KM, et al. Trajectories of Alcohol Initiation and Use During Adolescence: The Role of Stress and Amygdala Reactivity. J Am Acad Child Adolesc Psychiatry 2018; 57:550.</a></li><li><a class="nounderline abstract_t">Dawson DA, Goldstein RB, Chou SP, et al. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res 2008; 32:2149.</a></li><li><a class="nounderline abstract_t">Richter L, Pugh BS, Peters EA, et al. Underage drinking: prevalence and correlates of risky drinking measures among youth aged 12-20. Am J Drug Alcohol Abuse 2016; 42:385.</a></li><li class="breakAll">Centers for Disease Control and Prevention. High School YRBS. Youth Online. Alcohol and other drug use. https://nccd.cdc.gov/Youthonline/App/Default.aspx (Accessed on January 27, 2023).</li><li class="breakAll">Centers for Disease Control and Prevention. High School YRBS. Youth Online. Tobacco use. https://nccd.cdc.gov/Youthonline/App/Default.aspx (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Hingson R, Heeren T, Zakocs R. Age of drinking onset and involvement in physical fights after drinking. Pediatrics 2001; 108:872.</a></li><li><a class="nounderline abstract_t">Michaud PA, Bélanger R, Mazur A, et al. How can primary care practitioners address substance use by adolescents? A position paper of the EUROPEAN academy of PAEDIATRICS. Eur J Pediatr 2020; 179:1297.</a></li><li><a class="nounderline abstract_t">Tremblay M, Baydala L, Khan M, et al. Primary Substance Use Prevention Programs for Children and Youth: A Systematic Review. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320:1899.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement. JAMA 2020; 323:2301.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Krist AH, Davidson KW, et al. Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2020; 323:2060.</a></li><li><a class="nounderline abstract_t">O'Connor E, Thomas R, Senger CA, et al. Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2020; 323:2067.</a></li><li><a class="nounderline abstract_t">Patnode CD, Perdue LA, Rushkin M, et al. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2020; 323:2310.</a></li><li><a class="nounderline abstract_t">Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014. N Engl J Med 2017; 376:342.</a></li><li><a class="nounderline abstract_t">Striley CW, Kelso-Chichetto NE, Cottler LB. Nonmedical Prescription Stimulant Use Among Girls 10-18 Years of Age: Associations With Other Risky Behavior. J Adolesc Health 2017; 60:328.</a></li><li><a class="nounderline abstract_t">McCabe SE, Veliz P, Wilens TE, Schulenberg JE. Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study. J Am Acad Child Adolesc Psychiatry 2017; 56:226.</a></li><li><a class="nounderline abstract_t">Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002; 156:607.</a></li><li class="breakAll">About the CRAFFT. https://crafft.org/about-the-crafft/ (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">D'Amico EJ, Parast L, Meredith LS, et al. Screening in Primary Care: What Is the Best Way to Identify At-Risk Youth for Substance Use? Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Kelly SM, Gryczynski J, Mitchell SG, et al. Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics 2014; 133:819.</a></li><li><a class="nounderline abstract_t">Levy S, Weiss R, Sherritt L, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr 2014; 168:822.</a></li><li class="breakAll">National Institute on Alcohol Abuse and Alcoholism. Alcohol screening and brief intervention for youth: A practitioner's guide. http://www.niaaa.nih.gov/Publications/EducationTrainingMaterials/Pages/YouthGuide.aspx (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Zheng Y, Brendgen M, Girard A, et al. Peer Alcohol Use Differentially Amplifies Genetic and Environmental Effects on Different Developmental Trajectories of Adolescent Alcohol Use. J Adolesc Health 2019; 65:752.</a></li><li><a class="nounderline abstract_t">Chung T, Smith GT, Donovan JE, et al. Drinking frequency as a brief screen for adolescent alcohol problems. Pediatrics 2012; 129:205.</a></li><li><a class="nounderline abstract_t">O'Connor EA, Perdue LA, Senger CA, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018; 320:1910.</a></li><li><a class="nounderline abstract_t">Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics 2018; 141.</a></li><li class="breakAll">Centers for Disease Control and Prevention. High School YRBS. Youth Online. Unintentional injuries and violence. https://nccd.cdc.gov/Youthonline/App/Default.aspx (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Kemper AR, Hostutler CA, Beck K, et al. Depression and Suicide-Risk Screening Results in Pediatric Primary Care. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Richardson LP, Rockhill C, Russo JE, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics 2010; 125:e1097.</a></li><li><a class="nounderline abstract_t">Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41:1284.</a></li><li><a class="nounderline abstract_t">Shaffer D, Fisher P, Lucas CP, et al. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000; 39:28.</a></li><li><a class="nounderline abstract_t">LeBlanc JC, Almudevar A, Brooks SJ, Kutcher S. Screening for adolescent depression: comparison of the Kutcher Adolescent Depression Scale with the Beck depression inventory. J Child Adolesc Psychopharmacol 2002; 12:113.</a></li><li><a class="nounderline abstract_t">Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606.</a></li><li><a class="nounderline abstract_t">Richardson LP, McCauley E, Grossman DC, et al. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics 2010; 126:1117.</a></li><li class="breakAll">Guideline for Adolescent Depression in Primary Care (GLAD-PC) Toolkit. The REACH Institute, 2018. Available at: https://thereachinstitute.org/guidelines-for-adolescent-depression-primary-care/ (Accessed on January 30, 2023).</li><li class="breakAll">Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Supplemental information. Available at: https://pediatrics.aappublications.org/content/141/3/e20174081/tab-supplemental (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Forman-Hoffman V, McClure E, McKeeman J, et al. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med 2016; 164:342.</a></li><li><a class="nounderline abstract_t">Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA 2005; 293:311.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA 2022; 328:1534.</a></li><li><a class="nounderline abstract_t">Viswanathan M, Wallace IF, Cook Middleton J, et al. Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2022; 328:1543.</a></li><li><a class="nounderline abstract_t">COUNCIL ON COMMUNITY PEDIATRICS. Poverty and Child Health in the United States. Pediatrics 2016; 137.</a></li><li><a class="nounderline abstract_t">Palakshappa D, Fiks AG. Implications of Poverty for Practices Serving Suburban Families. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Sandel M, Sheward R, Ettinger de Cuba S, et al. Unstable Housing and Caregiver and Child Health in Renter Families. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Selvaraj K, Ruiz MJ, Aschkenasy J, et al. Screening for Toxic Stress Risk Factors at Well-Child Visits: The Addressing Social Key Questions for Health Study. J Pediatr 2019; 205:244.</a></li><li><a class="nounderline abstract_t">Roos LL, Wall-Wieler E, Lee JB. Poverty and Early Childhood Outcomes. Pediatrics 2019.</a></li><li><a class="nounderline abstract_t">Clark RE, Weinreb L, Flahive JM, Seifert RW. Infants Exposed To Homelessness: Health, Health Care Use, And Health Spending From Birth To Age Six. Health Aff (Millwood) 2019; 38:721.</a></li><li><a class="nounderline abstract_t">Nagata JM, Palar K, Gooding HC, et al. Food Insecurity Is Associated With Poorer Mental Health and Sleep Outcomes in Young Adults. J Adolesc Health 2019; 65:805.</a></li><li><a class="nounderline abstract_t">Thomas MMC, Miller DP, Morrissey TW. Food Insecurity and Child Health. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Drennen CR, Coleman SM, Ettinger de Cuba S, et al. Food Insecurity, Health, and Development in Children Under Age Four Years. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Hardy R, Boch S, Keedy H, Chisolm D. Social Determinants of Health Needs and Pediatric Health Care Use. J Pediatr 2021; 238:275.</a></li><li><a class="nounderline abstract_t">Wong-See H, Calik A, Ostojic K, et al. Clinical Pathways for the Identification and Referral for Social Needs: A Systematic Review. Pediatrics 2023; 151.</a></li><li><a class="nounderline abstract_t">Gottlieb LM, Adler NE, Wing H, et al. Effects of In-Person Assistance vs Personalized Written Resources About Social Services on Household Social Risks and Child and Caregiver Health: A Randomized Clinical Trial. JAMA Netw Open 2020; 3:e200701.</a></li><li><a class="nounderline abstract_t">Sokol R, Austin A, Chandler C, et al. Screening Children for Social Determinants of Health: A Systematic Review. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Dworkin PH, Garg A. Considering Approaches to Screening for Social Determinants of Health. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Brcic V, Eberdt C, Kaczorowski J. Development of a tool to identify poverty in a family practice setting: a pilot study. Int J Family Med 2011; 2011:812182.</a></li><li><a class="nounderline abstract_t">Brcic V, Eberdt C, Kaczorowski J. Corrigendum to "Development of a Tool to Identify Poverty in a Family Practice Setting: A Pilot Study". Int J Family Med 2015; 2015:418125.</a></li><li><a class="nounderline abstract_t">Garg A, Butz AM, Dworkin PH, et al. Improving the management of family psychosocial problems at low-income children's well-child care visits: the WE CARE Project. Pediatrics 2007; 120:547.</a></li><li><a class="nounderline abstract_t">COUNCIL ON COMMUNITY PEDIATRICS, COMMITTEE ON NUTRITION. Promoting Food Security for All Children. Pediatrics 2015; 136:e1431.</a></li><li><a class="nounderline abstract_t">Hager ER, Quigg AM, Black MM, et al. Development and validity of a 2-item screen to identify families at risk for food insecurity. Pediatrics 2010; 126:e26.</a></li><li><a class="nounderline abstract_t">Makelarski JA, Abramsohn E, Benjamin JH, et al. Diagnostic Accuracy of Two Food Insecurity Screeners Recommended for Use in Health Care Settings. Am J Public Health 2017; 107:1812.</a></li><li><a class="nounderline abstract_t">Baer TE, Scherer EA, Fleegler EW, Hassan A. Food Insecurity and the Burden of Health-Related Social Problems in an Urban Youth Population. J Adolesc Health 2015; 57:601.</a></li><li><a class="nounderline abstract_t">Shankar P, Chung R, Frank DA. Association of Food Insecurity with Children's Behavioral, Emotional, and Academic Outcomes: A Systematic Review. J Dev Behav Pediatr 2017; 38:135.</a></li><li><a class="nounderline abstract_t">Cutts DB, Meyers AF, Black MM, et al. US Housing insecurity and the health of very young children. Am J Public Health 2011; 101:1508.</a></li><li><a class="nounderline abstract_t">Garg A, Boynton-Jarrett R, Dworkin PH. Avoiding the Unintended Consequences of Screening for Social Determinants of Health. JAMA 2016; 316:813.</a></li></ol></div><div id="topicVersionRevision">Topic 2872 Version 89.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Minkovitz C, Wissow L. Evaluating and using laboratory tests. In: Oski's Pediatrics. Principles and Practice, 4th, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.95.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Fletcher RW, Fletcher SW. Prevention. In: Clinical Epidemiology The Essentials, 4th, Lippincott Williams &amp; Wilkins, Philadelphia 2005. p.147.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2201264" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Evaluating screening tests and screening programmes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10359392" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10359392" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10359392" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35921638" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : 2022 Recommendations for Preventive Pediatric Health Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35921638" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : 2022 Recommendations for Preventive Pediatric Health Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20923825" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20923825" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347426" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34710078" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Update of the Blood Lead Reference Value - United States, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34710078" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Update of the Blood Lead Reference Value - United States, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34710078" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Update of the Blood Lead Reference Value - United States, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27325637" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevention of Childhood Lead Toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19661858" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Recommendations for blood lead screening of Medicaid-eligible children aged 1-5 years: an updated approach to targeting a group at high risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30990555" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Screening for Elevated Blood Lead Levels in Childhood and Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30990556" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28771419" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : COUNCIL ON ENVIRONMENTAL HEALTH. Prevention of Childhood Lead Toxicity. Pediatrics. 2016;38(1):e20161493.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28771419" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : COUNCIL ON ENVIRONMENTAL HEALTH. Prevention of Childhood Lead Toxicity. Pediatrics. 2016;38(1):e20161493.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10718094" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Elevated blood lead levels among internationally adopted children--United States, 1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30996119" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Blood Lead Levels Among Resettled Refugee Children in Select US States, 2010-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30996119" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Blood Lead Levels Among Resettled Refugee Children in Select US States, 2010-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30996119" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Blood Lead Levels Among Resettled Refugee Children in Select US States, 2010-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231188" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A cost-effectiveness analysis of screening urine dipsticks in well-child care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231188" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A cost-effectiveness analysis of screening urine dipsticks in well-child care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28827377" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19414519" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Simple table to identify children and adolescents needing further evaluation of blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32094289" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Physical Activity Assessment and Counseling in Pediatric Clinical Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32094289" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Physical Activity Assessment and Counseling in Pediatric Clinical Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23713113" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Motor delays: early identification and evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30126932" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The Power of Play: A Pediatric Role in Enhancing Development in Young Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32250414" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Association of Physical Education With Improvement of Health-Related Physical Fitness Outcomes and Fundamental Motor Skills Among Youths: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30418471" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The Physical Activity Guidelines for Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33239350" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : World Health Organization 2020 guidelines on physical activity and sedentary behaviour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33239350" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : World Health Organization 2020 guidelines on physical activity and sedentary behaviour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35415743" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : mHealth Intervention for Motor Skills: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22084329" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30798614" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30798614" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27325634" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Substance Use Screening, Brief Intervention, and Referral to Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27325634" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Substance Use Screening, Brief Intervention, and Referral to Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27325634" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Substance Use Screening, Brief Intervention, and Referral to Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31235608" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Alcohol Use by Youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422269" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Alcohol Use Screening and Behavioral Counseling With Adolescents in Primary Care: A Call to Action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26324872" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Binge Drinking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27059911" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Screening for Underage Drinking and Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Alcohol Use Disorder in Rural Primary Care Practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30071976" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Trajectories of Alcohol Initiation and Use During Adolescence: The Role of Stress and Amygdala Reactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18828796" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26682472" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Underage drinking: prevalence and correlates of risky drinking measures among youth aged 12-20.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26682472" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Underage drinking: prevalence and correlates of risky drinking measures among youth aged 12-20.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26682472" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Underage drinking: prevalence and correlates of risky drinking measures among youth aged 12-20.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11581438" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Age of drinking onset and involvement in physical fights after drinking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32076808" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : How can primary care practitioners address substance use by adolescents? A position paper of the EUROPEAN academy of PAEDIATRICS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32769198" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Primary Substance Use Prevention Programs for Children and Youth: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422199" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515821" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32453374" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32453373" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515820" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28121512" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27998704" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Nonmedical Prescription Stimulant Use Among Girls 10-18 Years of Age: Associations With Other Risky Behavior.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28219488" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12038895" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12038895" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940696" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Screening in Primary Care: What Is the Best Way to Identify At-Risk Youth for Substance Use?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24753528" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25070067" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : An electronic screen for triaging adolescent substance use by risk levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25070067" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : An electronic screen for triaging adolescent substance use by risk levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31500948" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Peer Alcohol Use Differentially Amplifies Genetic and Environmental Effects on Different Developmental Trajectories of Adolescent Alcohol Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22218839" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Drinking frequency as a brief screen for adolescent alcohol problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422198" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29483200" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29483200" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34099503" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Depression and Suicide-Risk Screening Results in Pediatric Primary Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20368315" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14583691" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The Patient Health Questionnaire-2: validity of a two-item depression screener.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10638065" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12188980" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Screening for adolescent depression: comparison of the Kutcher Adolescent Depression Scale with the Beck depression inventory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11556941" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The PHQ-9: validity of a brief depression severity measure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21041282" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21041282" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21041282" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26857836" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15657324" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36219440" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36219399" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26962238" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Poverty and Child Health in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940719" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Implications of Poverty for Practices Serving Suburban Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29358482" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Unstable Housing and Caregiver and Child Health in Renter Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30297291" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Screening for Toxic Stress Risk Factors at Well-Child Visits: The Addressing Social Key Questions for Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31110161" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Poverty and Early Childhood Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31059358" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Infants Exposed To Homelessness: Health, Health Care Use, And Health Spending From Birth To Age Six.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31587956" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Food Insecurity Is Associated With Poorer Mental Health and Sleep Outcomes in Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31501236" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Food Insecurity and Child Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31501233" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Food Insecurity, Health, and Development in Children Under Age Four Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34329688" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Social Determinants of Health Needs and Pediatric Health Care Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36751899" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Clinical Pathways for the Identification and Referral for Social Needs: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32154888" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Effects of In-Person Assistance vs Personalized Written Resources About Social Services on Household Social Risks and Child and Caregiver Health: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31548335" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Screening Children for Social Determinants of Health: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31548336" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Considering Approaches to Screening for Social Determinants of Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22312547" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Development of a tool to identify poverty in a family practice setting: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26483977" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Corrigendum to "Development of a Tool to Identify Poverty in a Family Practice Setting: A Pilot Study".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17766528" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Improving the management of family psychosocial problems at low-income children's well-child care visits: the WE CARE Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26498462" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Promoting Food Security for All Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20595453" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Development and validity of a 2-item screen to identify families at risk for food insecurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28933929" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Diagnostic Accuracy of Two Food Insecurity Screeners Recommended for Use in Health Care Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26592328" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Food Insecurity and the Burden of Health-Related Social Problems in an Urban Youth Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28134627" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Association of Food Insecurity with Children's Behavioral, Emotional, and Academic Outcomes: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21680929" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : US Housing insecurity and the health of very young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27367226" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Avoiding the Unintended Consequences of Screening for Social Determinants of Health.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
